From CE Mark to First Sale?
Dr. Stefan Walzer (MArS) and Thibault Vandenhove (Ooho) walk the MedTech go-to-market timeline, from study design to first sale.
.jpg)
Watch the recording
Fill in your details to watch the full recording. The written recap below is free to read.
Recap
About the session
Market access and commercial launch both start at study design, not after approval. MedTech companies that wait pay for it twice: once in a study that cannot carry a price argument, and again in a launch nobody was warmed up for.
Dr. Stefan Walzer (MArS Market Access & Pricing Strategy) and Thibault Vandenhove (Ooho) walk the full MedTech go-to-market timeline live, moderated by Lutz Vollmer (MArS). A live discussion with Q&A.
Who it is for
MedTech founders and commercial teams on the road from CE mark to their first commercial sale.
Wednesday 28 October 2026, 17:00 CET, 45 minutes, online via Microsoft Teams.
Co-hosted by MArS Market Access & Pricing Strategy and Ooho.
Speakers
%20(1).jpg)
.jpg)
%20(2).jpg)